Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study

[1]  U. Specks.  Pro: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab? , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  P. Ravaud,et al.  Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty‐Five Years or Older: Results of a Multicenter, Open‐Label, Randomized Controlled Trial of Corticosteroid and Cyclophosphamide–Based Induction Therapy , 2015, Arthritis & rheumatology.

[3]  R. Caporali,et al.  FRI0278 Life-Threatening Onset of Systemic Vasculitis Requiring Intensive Care Unit Admission: A Case Series , 2015, Clinical and experimental rheumatology.

[4]  K. Klouche,et al.  Prognosis and ICU outcome of systemic vasculitis , 2013, BMC Anesthesiology.

[5]  B. Bonnotte,et al.  Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides. , 2013, Presse medicale.

[6]  V. Lánská,et al.  Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study , 2013, Scandinavian journal of rheumatology.

[7]  Myrna M. Khan,et al.  A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers , 2013, BMJ Open.

[8]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[9]  L. Mouthon,et al.  The Five-Factor Score Revisited: Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort , 2011, Medicine.

[10]  P. Merkel,et al.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis. , 2010, The New England journal of medicine.

[11]  P. Seo.  Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis , 2010 .

[12]  David Steven Scott,et al.  Modification and validation of the Birmingham Vasculitis Activity Score (version 3) , 2008, Annals of the rheumatic diseases.

[13]  Jay Steingrub,et al.  International study of the prevalence and outcomes of infection in intensive care units , 2009 .

[14]  J. Roman,et al.  Prognostic Factors for Hospital Mortality and ICU Admission in Patients With ANCA-Related Pulmonary Vasculitis , 2008, The American journal of the medical sciences.

[15]  R. Luqmani,et al.  Mortality in systemic vasculitis: a systematic review. , 2008, Clinical and experimental rheumatology.

[16]  V. Tesar,et al.  Outcome of Thirty Patients with ANCA-Associated Renal Vasculitis Admitted to the Intensive Care Unit , 2008, Renal failure.

[17]  D. Abramowicz,et al.  Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. , 2007, Journal of the American Society of Nephrology : JASN.

[18]  S. A. Khan,et al.  Outcome of patients with small-vessel vasculitis admitted to a medical ICU. , 2007, Chest.

[19]  C. Mélot,et al.  Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit , 2005, Intensive Care Medicine.

[20]  L. Forni,et al.  Clinical review: Vasculitis on the intensive care unit – part 2: treatment and prognosis , 2004, Critical care.

[21]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[22]  S. Aymé,et al.  Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. , 2004, Arthritis and rheumatism.

[23]  L. Mouthon,et al.  Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. , 2003, Rheumatology.

[24]  S. Chevret,et al.  Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. , 1997, The Journal of rheumatology.

[25]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.

[26]  Gerwig Wh,et al.  Surgical intensive care unit. , 1962 .